Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators
- 15 March 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (6) , 1565-1571
- https://doi.org/10.1016/j.bmcl.2005.01.077
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humansPsychopharmacology, 2003
- The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and PharmacologyCurrent Drug Targets-CNS & Neurological Disorders, 2002
- Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of SchizophreniaCurrent Drug Targets-CNS & Neurological Disorders, 2002
- Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor AgonistsJournal of Medicinal Chemistry, 2000
- Pharmacological agents acting at subtypes of metabotropic glutamate receptorsPublished by Elsevier ,1999
- Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795European Journal of Pharmacology, 1999
- Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740): Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate ReceptorsJournal of Medicinal Chemistry, 1999
- Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemiaNeuroscience Letters, 1998
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic PropertiesJournal of Medicinal Chemistry, 1997